ICICI Prudential US Bluechip Equity Fund - Growth - Regular Plan

Other Plans and Options
  • 1.39 %Nav, as on 11-09-2025

  • Previous Nav

  • Net Change on 11-09-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential US Bluechip Equity Fund - Growth 23.59 28.41 7.40 15.30 14.81 15.52
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P 500 2.23 8.17 18.86 17.07 14.35 8.09

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential US Bluechip Equity Fund - Growth Jul 06, 2012 7.40 15.30 14.81 2.00 3,356.51
Motilal Oswal S&P 500 Index Fund - Regular Plan Growth Apr 28, 2020 24.23 21.55 17.84 1.13 3,886.69
Nippon India US Equity Opportunites Fund- Growth Plan- Growth Option Jul 23, 2015 17.11 16.99 13.49 2.38 713.51
Nippon India Japan Equity Fund- Growth Plan- Growth Option Aug 26, 2014 19.28 17.21 9.07 2.45 283.56

Fund Holdings as on 31-August-2025

  • West Pharmaceutical Services Inc

  • Estee Lauder Cos Inc

  • Huntington Ingalls Industries Inc

  • Nike Inc

  • Zimmer Biomet Holdings Inc

  • Alphabet Inc

  • Agilent Technologies Co Ltd

  • US Bancorp Inc

  • Monolithic Power Systems Inc

  • Boeing Co

  • NXP Semiconductors NV

  • Pfizer Inc

  • GE HealthCare Technologies Inc

  • MarketAxess Holdings Inc

  • Bio-Rad Laboratories Inc

  • Brown-Forman Corp

  • TERADYNE INC

  • International Flavors & Fragrances Inc

  • Danaher Corp

  • United Parcel Service Inc

  • Allegion plc

  • Constellation Brands Inc

  • Campbell Soup Co

  • Adobe Inc

  • Walt Disney

  • Salesforce.Com Inc

  • IDEX Corp

  • TRANSUNION

  • Thermo Fisher Scientific Inc

  • Applied Material (US)

  • Microsoft Corp

  • TREPS

  • Northrop Grumman Corp

  • Charles Schwab Corp

  • Corteva Inc

  • Amazon com

  • Merck & Co Inc

  • Veeva Systems Inc

  • Amgen Inc

  • Microchip Technology Inc.

  • Oracle Corp

  • Bristol-Myers Squibb Co

  • Mondelez International Inc

  • Masco Corp.

  • Cadence Design Systems Inc

  • The Clorox Company

  • Autodesk

  • Pepsico Inc

  • Kenvue Inc

  • Manhattan Associates Inc

  • Synopsys Inc

  • Workday Inc

  • Hershey Co

  • Biogen Inc

  • Occidental Petroleum Corp

  • Freeport-McMoRan Inc

  • Qualcomm Inc.

  • Comcast Corporation

  • Epam Systems Inc

  • Nordson Corporation .

  • Lam Research Corporation

  • ASML Holding NV-NY REG SHS

  • Yum China Holdings Inc.

  • Alphabet Inc

  • Caterpillar Inc.

  • Medtronic Plc

  • Net Current Assets

View More

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About ICICI Prudential US Bluechip Equity Fund

Scheme Analysis

ICICI Prudential US Bluechip Equity Fund is a Equity - Thematic Fund - Global fund and belongs to ICICI Prudential Mutual Fund. It was launched on 06-Jul-2012 and currently has an AUM of ₹3,356.51 crore. ICICI Prudential US Bluechip Equity Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P 500 as secondary index.

The NAV of ICICI Prudential US Bluechip Equity Fund ended up ₹0.93(1.39%)yesterday to ₹67.97.

Among its top 3 holdings the fund has exposure to West Pharmaceutical Services Inc, and

The ICICI Prudential US Bluechip Equity Fund is managed by Ritesh Lunawat and Sharmila Dmello.

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100